Age, sex, BMI, Incidence, vs 0.88 ≥30 ≤0 energy intake, colorectal g/day energy-adjusted cancer, men NLCS, Kampman, intake of dietary Case Cohort, 326/ 1994 Population fiber, Midpoint, distribution of Age: 55-69 120 852 COL00155 registries intake of person-years Incidence, years, 3.3 years FFQ 0.61 Netherlands fat, family history colorectal Q 4 vs Q 1 M/W of specific cancer, cancer, history of gallbladder surgery Table 122 Cheese intake and colorectal cancer risk. Main characteristics of studies excluded from the CUP SLR dose-response analysis Author, Cases/ Study name, Year, Study size Case Exposure Adjustment Reasons for Outcome Comparison RR (95%CI) WCRF Code, Follow-up ascertainment assessment factors exclusion Country (years) Mortality, vs /week 0.81 (0.41-1.61) ≥5 ≤2 cancer, women JACC, Municipal Mortality, colon Prospective vs /week 1.10 (0.62-1.96) ≥5 ≤2 Iso, 2007 176/ resident cancer, men Cohort, Mortality as COL40707 105 500 registration FFQ Age, centre location Age: 40-79 outcome Mortality, rectal Japan 15 years records, death vs /week 1.48 (0.78-2.79) years, ≥5 ≤2 cancer, men certificates M/W Mortality, rectal vs /week 0.80 (0.25-2.61) ≥5 ≤2 cancer, women
Kampman, 1994 COL00155 Netherlands NLCS, Case Cohort, Age: 55-69 years, M/W 326/ 120 852 3.3 years Population registries FFQ Incidence, colorectal cancer, men ≥30 vs ≤0 g/day 0.88 Age, sex, BMI, energy intake, energy-adjusted intake of dietary fiber, intake of fat, family history of specific cancer, history of gallbladder surgery Midpoint, distribution of person-years Incidence, colorectal cancer, Q 4 vs Q 1 0.61 Table 122 Cheese intake and colorectal cancer risk. Main characteristics of studies excluded from the CUP SLR dose-response Author, Year, WCRF Code, Country Study name, Cases/ Study size Follow-up (years) Case ascertainment Exposure assessment Outcome Comparison RR (95%CI) Adjustment factors Reasons for exclusion Iso, 2007 COL40707 Japan JACC, Prospective Cohort, Age: 40-79 years, M/W 176/ 105 500 15 years Municipal resident registration records, death certificates FFQ Mortality, cancer, women ≥5 vs ≤2 /week 0.81 (0.41-1.61) Age, centre location Mortality as outcome Mortality, colon cancer, men ≥5 vs ≤2 /week 1.10 (0.62-1.96) Mortality, rectal cancer, men ≥5 vs ≤2 /week 1.48 (0.78-2.79) Mortality, rectal cancer, women ≥5 vs ≤2 /week 0.80 (0.25-2.61) analysis
CUP_colorectal_SLR_2016_RO.docx